Also found in: Wikipedia.
CRISPRClustered Regularly Interspaced Short Palindromic Repeat
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.
WiseGuyReports have announced the addition of a new report titled "Global CRISPR Market Size, Status and Forecast 2019-2025".
The LGR is the brainchild of Professor Jennifer Doudna, University of California Berkeley (UCB), a co-inventor of CRISPR technology and Howard Hughes Medical Institute (HHMI) Investigator; Professor Jonathan Weissman, University of California San Francisco (UCSF), a pioneer of CRISPR screening technology and HHMI Investigator; and Dr Hal Barron, Chief Scientific Officer and President, R&D, GSK.
In the latest critique of his approach, a paper published in the PLOS biology by Haoyi Wang and Hui Yang from the Chinese Academy of Sciences, says there is no sound scientific reason to perform CRISPR on human germline.
[ClickPress, Tue Apr 16 2019] Looking at the current market trends as well as the promising demand status of the " CRISPR and Cas Genes Market ", it can be projected that the future years will bring out positive outcomes.
A Cornell researcher, who is a leader in developing a new type of gene editing CRISPR system, and colleagues have used the new method for the first time in human cells -- a major advance in the field.
Jiankui claims to have used CRISPR and Cas9 to turn off expression of the CCR5, a protein that plays a part in our immune system.
John Schoggins, Assistant Professor of Microbiology, used the cutting-edge CRISPR technology to identify the IFI6 gene as a potent antiviral gene targeting flaviviruses.
[13] However, such sweeping statements seem to ignore the evolution of mutagenesis techniques from those that caused widespread and unspecific mutations, such as irradiation, to that of CRISPR, which promises better specificity.
Imagine a future where large corporations use CRISPR, a genetic